A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy
- 1 November 1995
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 72 (5), 1289-1293
- https://doi.org/10.1038/bjc.1995.502
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Tumour induced hypercalcaemia: A case for active treatmentClinical Oncology, 1994
- Single-dose intravenous therapy with pamidronate for the treatment of hypercalcemia of malignancy: Comparison of 30-, 60-, and 90-mg dosagesAmerican Journal Of Medicine, 1993
- Cancer-Associated Hypercalcemia: Morbidity and MortalityAnnals of Internal Medicine, 1990
- Analysis of serial measurements in medical research.BMJ, 1990
- COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1989
- Dose/response study of aminohydroxypropylidene bisphosphonate in tumor-associated hypercalcemiaAmerican Journal Of Medicine, 1987
- Clodronate. A randomized study in the treatment of cancer-related hypercalcemiaArchives of Internal Medicine, 1987
- COMPARISON OF AMINOHYDROXYPROPYLIDENE DIPHOSPHONATE, MITHRAMYCIN, AND CORTICOSTEROIDSICALCITONIN IN TREATMENT OF CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1985
- RENAL FAILURE ASSOCIATED WITH INTRAVENOUS DIPHOSPHONATESThe Lancet, 1983
- Hypercalcaemia--a hospital survey.1980